Implementation of a Protocol for Peripheral Intravenous Norepinephrine: Does It Save Central Line Insertion, Is It Safe?

Kari M CapeLaureen G JonesMichele L WeberJessica L Elefritz

Published in: Journal of pharmacy practice (2020)

Our results suggest that norepinephrine is safe to administer through a PIV at low doses for less than 24 hours using a protocol. Prevention of unnecessary CVC insertion is beneficial by minimizing the risk of central line complications thus improving patient morbidity.

Keyphrases

randomized controlled trial
primary care
healthcare
case report
high dose
risk factors
quality improvement
chemotherapy induced